Nicotine Treatment of Mild Cognitive Impairment (MCI)

This study is ongoing, but not recruiting participants.
Information provided by National Institute on Aging (NIA)

Find Related Studies by Searching for the Conditions, Interventions, and Sponsors found in this study:

1		Conditions listed in this trial
			Age-Related Memory Disorders
2		Additional conditions recognized in this trial
			Memory Disorders
3		More general conditions related to this trial
			Nervous System Diseases
			Neurobehavioral Manifestations
			Neurologic Manifestations
			Signs and Symptoms
4		Interventions listed in this trial
			Transdermal nicotine patch
			Placebo transdermal patch
5		Additional drug interventions recognized in this trial
			Nicotine
			Nicotine polacrilex
6		More general drug interventions related to this trial
			Autonomic Agents
			Central Nervous System Agents
			Central Nervous System Stimulants
			Cholinergic Agents
			Cholinergic Agonists
			Ganglionic Stimulants
			Molecular Mechanisms of Pharmacological Action
			Neurotransmitter Agents
			Nicotinic Agonists
			Peripheral Nervous System Agents
			Pharmacologic Actions
			Physiological Effects of Drugs
			Therapeutic Uses
7		Sponsors listed in this trial
			National Institute on Aging (NIA)